برای نمایش بهتر وب سایت از ورژن جدید مرورگر فایرفاکس یا گوگل کروم استفاده نمایید.

دانلود ورژن جدید فایرفاکس دانلود ورژن جدید کروم

  مقالات چاپ شده با افیلیشن مرکز


 
  Title Researcher Author position Journal SJR INDEX IF Year  Center Affiliation  Rank
1 Multiple Functions of Long Non-Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer Progression. Bahman Yousefi
 
Corresponding Journal of Cellular Biochemistry Q2/1.21 ISI 2.95 Jan/2018 first 30.9
2 Combined post conditioning with ischemia and cyclosporine-A restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium. Reza Badalzadeh First Iranian Journal of Basic Medical Sciences Q2/0.54 ISI 1.51 Oct/2017 first 28.02
3 Halomonas tabrizica sp. nov., a novel moderately halophilic bacterium isolated from Urmia Lake in Iran Mohammad Saeid Hejazi/ Vahideh Tarhriz Corresponding/ Third Antonie Van Leeuwenhoek Q2/0.83 ISI 1.79 Jul/2018 first/2nd 28.58/
14.29
4 Removal of U(VI) from aqueous solutions using Shewanella sp. RCRI7, isolated from Qurugöl Lake in Iran Vahideh Tarhriz/ Mohammad Saeid Hejazi 4th/5th
 
RDIOCHIMICA ACTA Q3/0.47 ISI 1.1 Oct/2016 2nd 9.06
5 Development of a new sequential block finding strategy for detection of conserved sequences in riboswitches Mohammad Saeid Hejazi
 
Corresponding BIoImpacts Q2/0.75 ISI 3.23 Sep/2018 first 31.46
6 The role of CIP2A in cancer: A review and update Mohammad Saeid Hejazi 2nd BIOMED PHARMACOTHER Q2/0.83 ISI 2.75 Dec/2017 first 15.25
7 siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells Mohammad Saeid Hejazi corresponding Advanced Pharmaceutical Bulletin Q1/0.63 ISI - Dec/2017 first 25
8 DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications. Bahman Yousefi
 
corresponding DNA Repair Q1/3.181 ISI 4.46 Sep/2018 first 33.92
9 Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury. Reza Badalzadeh corresponding Eur J Prev Cardiol Q1/2.01 ISI 4.54 Sep/2018 2nd 34.08
10 Shielding properties of the ordinary concrete loaded with micro- and nano-particles against neutron and gamma radiations Asghar Mesbahi First Appl Radiat Isot Q2/0.53 ISI 1.23 Jun/2018 first 27.46
11 Epigenetic mechanisms as a new approach in Cancer treatment: An updated review. Saeed Solali 2nd Genes & Diseases Q1/2.05 ISI 1.46 Jun/2018 first 13.96
 
12 Nutrigenomics, Epigenetics and Pain in Cancer/ Book Saeed Pirouxpanah First Cancer Genetics and sychotherapy       Sep/2017 first  
13 Anti-arrhythmogenic and anti-inflammatory effects of troxerutin in ischemia/reperfusion injury of diabetic myocardium Reza Badalzadeh corresponding Biomed Pharmacother Q1/0.951 ISI 3.457 Jun/2018 2nd 32.08
14 Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes Saeed Pirouxpanah first Cancer Biomark Q2/0.83 ISI 2.39 Feb/2018 2nd 29.78
15 Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL Saeed Solali corresponding J Cell Physiol Q1/1.64 ISI 4.80 Oct/2018 first 34.6
16 Protective effect of ghrelin on testicular damages caused by chronic hypoxia in rats: A histopathological stud Alireza Alihemmati corresponding ANDROLOGIA Q2/0.63 ISI 1.58 Jan/2016 first 28.16
17 Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance Bahman Yousefi
 
corresponding Journal of Cellular Physiology Q1/1.64 ISI 3.92 Dec/2018 first 32.84
18 Anoxybacillus sediminis sp. nov., a novel moderately thermophilic bacterium isolated from a hot spring. Mohammad Saeid Hejazi 5th Antonie van Leeuwenhoek Q1/0.53 ISI 1.58 Jul/2018 first 9.38
19 Riboswitches: From living biosensors to novel targets of antibiotics Elnaz Mehdizadeh First GENE Q1/1.1 ISI 2.49 Nov/2017 2nd 29.98
20 CDK9 as an Appealing Target for Therapeutic Interventions Vahideh Tarhriz/ Mohammad Saeid Hejazi Corresponding/ 2nd CURRENT DRUG TARGETS Q2/.92 ISI 3.11 Nov/2018 first 31.22/
15.61
21 Exosomes: natural nanoparticles as bio shuttles for RNAi delivery Bahman Yousefi
 
corresponding JOURNAL OF CONTROLLED RELEASE Q1/2.69 ISI 7.88 Oct/2018 first 40.6
22 CDK9 Regulates Apoptosis of Myoblast Cells by Modulation of microRNA-1 Expression. Vahideh Tarhriz/Mohammad Saeid Hejazi
 
First/ corresponding Journal of Cellular Biochemistry Q1/1.21 ISI 3.46 Jul/2018 first 31.92
22 TPP riboswitch characterization in Alishewanella tabrizica and Alishewanella aestuarii and comparison with other TPP riboswitches. Elnaz Mehdizadeh / Mohammad Saeid Hejazi /
Vahideh Tarhriz/
First/ corresponding/ third
 
Microbiology research Q2/1.01 ISI 2.77 Jan/2017 First/2nd 30.54/
30.54/
15.27
23 Double sword role of EZH2 in leukemia Saeed Solali corresponding Biomedicine and Pharmacotherapy Q2/0.83 ISI 2.23 Jan/2017 first 29.46
24 Combined postconditioning with ischemia and cyclosporine-A restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium Reza Badalzadeh First/ corresponding Iranian Journal of Basic Medical Sciences Q2/0.52 ISI 1.42 Oct/2017 first 27.84
25 Overview of CD24 as a new molecular marker in ovarian Cancer Vahideh Tarhriz first Journal of Cellular Physiology Q1/1.64 ISI 3.92 Sep/2018 first 32.84
26 Bioreduction of iron and biosorption of Heavy Metal (Ni2+, Co2+, pb2+) by a novel environmental bacterium, Tabrizicola aquatica RCRI19T
 
Mohammad Saeid Hejazi/
Vahideh Tarhriz/
Corresponding/ First/ Asian Journal of Water, Environment and Pollution - IOS Press
 
Q3/0.16 ISI - Jun/2018 First 25
27 Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity Reza Badalzadeh Corresponding Advanced Pharmaceutical Bulletin Q1/0.63 ISI - Jun/2018 third 25
28 New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance Bahman Yousefi
 
Corresponding Journal of Cellular Physiology Q1/1.64 ISI 3.92 Nov/2018 first 32.84
29 53BP1: A key player of DNA damage response with critical functions in cancer Bahman Yousefi
 
Corresponding DNA Repair Q1/3.181 ISI 4.46 Nov/2018 first 33.92
30 MiRNAs and inflammatory bowel disease: An interesting new story Bahman Yousefi
 
corresponding Journal of Cellular Physiology Q1/1.64 ISI 3.92 Nov/2018 2nd 32.84
31 Potential of Peptide Nucleic Acids in Future Therapeutic Applications Soheila Montazersaheb/
Mohammad Saeid Hejazi
Corresponding/
Second
Advanced Pharmaceutical Bulletin Q1/0.63 ISI - Nov/2018 2nd/first 25/12.5
32 Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells. Soheila Montazersaheb
 
First Biomedicine and pharmacotherapy Q1/0.95 ISI 3.457 Sep/2018 first 31.92
33 Downregulation of TdT expression through splicing modulation by antisense peptide nucleic acids (PNA) Soheila Montazersaheb/
Mohammad Saeid Hejazi
First/
Corresponding
Current Pharmaceutical Biotechnology Q2/0.57 ISI 2.14 Nov/2018 2nd/first 29
34 Layered Double Hydroxide Nanoparticles as an Appealing Nanoparticle in Gene/Plasmid and Drug Delivery System in C2C12 Myoblast Cells Vahideh Tarhriz/ Elham Mansouri/ Mohammad Saeid Hejazi/ Asghar Mesbahi Corresponding/ 2nd/4th / 5th Artificial Cells, Nanomedicine and Biotechnology Q2/0.49 ISI 3.2 Nov/2018 first 31.4
35 A novel mixed hemimicelles dispersive micro-solid phase extraction using ionic liquid functionalized magnetic graphene oxide/polypyrrole for extraction and pre-concentration of methotrexate from urine samples followed by the spectrophotometric method Elnaz Mehdizadeh Corresponding Clinica Chimica Acta Q1/1.1 ISI 2.53 Jan/ 2019 2nd 30.06
36 The MicroRNA-326: Autoimmune diseases, diagnostic biomarker, and therapeutic target Gholamreza  Jadideslam First Journal of Cellular Physiology Q1/1.64 ISI 3.92 Dec/2018 First 32.84